While much of the biopharma industry has spent the past 12 months treading lightly around the Trump administration and the tumult it has wrought on U.S. medical research and regulation, Pfizer’s CEO ...
In an interview with At Barron's Andy Serwer in Davos, Switzerland, Albert Bourla says he is betting his pension on Pfizer stock. This interview was recorded on Jan. 15, 2024, at the World Economic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results